Chart-Typ:
Zeitraum:
| Clinuvel Pharmaceuticals Limited: CLINUVEL expands Singapore RD&I Centre to pioneer next-generation peptide therapies | EXECUTIVE SUMMARY VALLAURIX Research, Development & Innovation Centre to expand its existing facilities and capabilities core focus on accelerating development of liquid long-acting drug delivery... ► Artikel lesen |
| Original-Research: CLINUVEL Pharmaceuticals Limited (von Parmantier & Cie. GmbH): Buy | Original-Research: CLINUVEL Pharmaceuticals Limited - from Parmantier & Cie. GmbH
30.09.2025 / 10:52 CET/CEST
Dissemination of a Research, transmitted by EQS News - a service of EQS Group.
The... ► Artikel lesen |
| Clinuvel Pharmaceuticals Limited: CLINUVEL to advance novel pharmaceutical formulations in preclinical program | Executive summary first biocompatible pharmaceutical formulations progress to preclinical modelsnew sustained-release drug delivery platforms for peptides, melanocortinsaim to predict drug release... ► Artikel lesen |
| Auxly Cannabis Group Inc.: Auxly Reports Third Quarter 2025 Results | TORONTO, Nov. 13, 2025 /PRNewswire/ - Auxly Cannabis Group Inc. (TSX: XLY) (OTCQB: CBWTF) ("Auxly" or the "Company") a leading consumer packaged goods company in... ► Artikel lesen |
| Auxly Cannabis Group Inc.: Auxly Reports Second Quarter 2025 Results | TORONTO, Aug. 14, 2025 /PRNewswire/ - Auxly Cannabis Group Inc. (TSX: XLY) (OTCQB: CBWTF) ("Auxly" or the "Company") a leading consumer packaged goods company... ► Artikel lesen |
| Auxly Cannabis Group Inc.: Auxly Announces Results of Annual General Meeting of Shareholders | TORONTO, July 2, 2025 /CNW/ - Auxly Cannabis Group Inc. (TSX: XLY) (OTCQB: CBWTF) ("Auxly" or the "Company") announced today the voting results from its annual... ► Artikel lesen |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu WISON ENGINEERING SERVICES CO LTD finden Sie auf Wallstreet Online.